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Summary 
  
The IGF system of growth factors, recep-
tors and binding proteins functions from early 
in pregnancy. Recent evidence indicates im-
proved embryo survival in gilts fed supple-
mental omega-3 fatty acids beginning before 
conception. Here we report effects of supple-
menting a corn-soybean meal diet (control) 
with a marine source of protected omega-3 
fatty acids (PFA, 1.5% of diet) on mRNA ex-
pression for IGF-I, IGF-II, IGF Binding Pro-
tein-3 (IGFBP-3) and IGFBP-5 in the porcine 
gravid uterus. The PFA (Gromage™) con-
tained equal amounts of eicosapentanoic 
(EPA) and docosahexanoic (DHA) acids and 
replaced corn in the diet beginning when gilts 
were approximately 170 d old (n = 13/treat-
ment).  
 
Gilts were artificially inseminated at ap-
proximately 205 d of age. Conceptus and en-
dometrial samples were collected on d 11, 15, 
and 19 of gestation. All gilts were pregnant.  
 
In the conceptus, message for IGF-II and 
IGFBP-3 increased (P<0.001) from d 15 to d 
19, while there was an increase (P < 0.001) in 
IGF-I and IGFBP-5 from d 11 to 15 and a de-
crease (P<0.001) to d 19. In the endometrium, 
message for IGF-I was stable over the inter-
val, but message for IGF-II and IGFBP-5 were 
increased by d 15 and IGFBP-3 by d 19 
(P<0.01). There were trends for omega-3 fatty 
acid supplementation to increase endometrial 
IGF-II (P = 0.09) and IGFBP-5 (P = 0.12) on 
d 15. In the d-19 conceptus, embryonic but not 
extraembryonic IGF-I mRNA tended to be 
greater (P = 0.13) for PFA compared to con-
trol gilts. During d 11 to 19 the conceptus is 
elongating, attaching to the uterus, and the 
embryonic disc is differentiating from a ho-
mogenous tissue to form the tissues and or-
gans of the adult. One mechanism for omega-
3 fatty acid effects in early pregnancy could 
involve epigenetic effects on mRNA expres-
sion for the IGF and IGFBP proteins.  
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Introduction 
 
 Published research indicates that the insu-
lin-like growth factor system includes three 
hormones, IGF-I, IGF-II, and insulin, and six 
binding proteins, IGFBP-1 through IGFBP-6.  
Insulin-like growth factor (IGF)–I and –II are 
proteins that are important regulators of fetal 
and postnatal growth. 
 
 IGF-I is present in most fetal tissues as 
early as the embryonic stage.  IGF-II is the 
prominent growth factor during fetal growth 
and development.  IGFBP-3 is the most abun-
dant binding protein, and it binds approxi-
mately 90% of the IGFs in circulation.  
IGFBP-5 is the most conserved binding pro-
tein across species and is an essential regulator 
of physiological processes.   
 
Materials and Methods 
 
At 150 d of age, 26 gilts (PIC 327MQ × 
1050; BW = 131 kg) were exposed to boars to 
induce puberty.  At 170 d of age, gilts were 
moved to gestation stalls and dietary treat-
ments were initiated.   
Gilts were randomly assigned to one of 
two dietary treatments.  The control treatment 
consisted of a typical corn-soybean meal diet.  
The treatment called PFA was the control diet 
with an added protected fish source of omega-
3 fatty acids.  This product, Gromega™, was 
added at 1.5 percent of the diet in place of 
corn. 
 
At approximately d 190, a 14-d Matrix® 
treatment was applied for estrus synchroniza-
tion.  After the Matrix® treatment and upon 
heat detection, gilts were artificially insemi-
nated with semen from the PIC line 1050 
boars.  Dietary treatments continued until days 
eleven, fifteen, and nineteen of gestation (d 0 = 
onset of estrus) when gilts underwent surgery 
to remove embryos and tissue samples.  Prior 
to the trial, gilts were pen fed, ad libitum.  
Once moved to gestation stalls, gilts were fed 5 
lb per day for the remainder of the trial. 
 
Thirteen gilts were allotted per treatment.  
All were pregnant at surgery and provided 
samples for mRNA measurement.  Total RNA 
was isolated from endometrium, extraembry-
onic membrane, and embryos by using the 
RNeasy Mini Kit (Qiagen; Valencia, CA).  The 
concentration of RNA was determined by ab-
sorbance at 260 nm.  Electrophoresis of total 
RNA through a 1% agarose-formaldehyde gel 
followed by ethidium bromide staining al-
lowed visualization of 28S and 18S ribosomal 
RNA (rRNA) and was used to assess the integ-
rity of RNA.  One microgram of total RNA 
was reverse-transcribed to produce the first-
strand complementary DNA (cDNA) using 
TaqMan reverse transcriptase (Applied Biosys-
tems, Foster City, CA) following the protocol 
recommended by the manufacturer.  
 
  Real-time quantitative-PCR was used to 
measure the quantity of mRNA for IGF-I, IGF-
II, IGFBP-3, and IGFBP-5 and 18S rRNA in 
total RNA isolated from endometrium, ex-
traembryonic membranes, and embryos.  
Measurement of the relative quantity of cDNA 
was carried out using TaqMan Universal PCR 
Master Mix (Applied Biosystems), 900 nM of 
the appropriate forward and reverse primers, 
200 nM of the appropriate TaqMan detection 
probe, and 1 µL (0.5 µg cDNA) of the cDNA 
mixture.  Commercially available eukaryotic 
18S rRNA primers and probes were used as an 
endogenous control (Applied Biosystems; 
Genbank Accession no. X03205).  Assays 
were preformed in an ABI Prism 7000 se-
quence detection system (Applied Biosystems) 
using thermal cycling parameters recom-
mended by the manufacturer (50 cycles of 15 
sec at 95ºC and 1 min at 60ºC).  Relative ex-
pressions of mRNA of IGF-I, IGF-II, IGFBP-
3, and IGFBP-5 were normalized to the 18S 
rRNA endogenous control and expressed in 
arbitrary units.  Primers and probes were used 
for the real-time quantitative-PCR.   
 
  Data were analyzed using the MIXED 
procedure of SAS (SAS, 2000; SAS Inst. Inc., 
the Satterthwaite degrees of freedom).    
 
Results 
 
 In the endometrium, as day of gestation 
increased, the mRNA for all of the IGF pro-
teins except IGF-I increased.  Within the con-
ceptus, the mRNAs for all the IGF proteins 
increased (P < 0.001) with increasing day of 
gestation. Within the conceptus on d 19 of 
gestation, the embryo contained more (P = 
0.056) IGF-I mRNA than the extraembryonic 
tissue, and there was a trend for a tissue by 
treatment interaction (P = 0.13) because PFA 
tended to increase IGF-I message in the em-
bryo but not in the extraembryonic tissue.  
There was also a tendency (P<0.09) for the 
extraembryonic membranes to contain more 
IGFBP-3 message (30.2 ± 5.6) than the em-
bryo (15.6 ± 5.6).  
 
In the endometrium, IGF-II message was 
greater (P<0.05) on d 15 and d 19 than on d 
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11, and there was a tendency (P = 0.09) for a 
d × treatment interaction because PFA tended 
to increase IGF-II message on d 15 but not on 
other days.  In the endometrium IGFBP-5 
mRNA was greater (P<0.05) on d 15 and d 19 
than on d 11, and a trend for a treatment × day 
effect (P<0.12) because PFA tended to in-
crease IGFBP-5 mRNA on d 15 but decrease 
its message on d 19.  
 
Discussion 
 
 There were no strong treatment effects of 
omega-3 fatty acid supplementation on IGF-I, 
IGF-II, IGFBP-3, or IGFBP-5 in the endo-
metrium; however, tendencies for d × treat-
ment interactions for IGF-II and IGFBP-5 oc-
curred because PFA tended to increase their 
mRNAs on d 15 but not other days.  Because 
the mRNA for these two proteins also in-
creased on d 15 it may be that this period of 
transition is responsive to omega-3 fatty acid 
supplementation.  There was also a tendency 
for PFA to increase IGF-I mRNA in the em-
bryo on d 19.  The dietary fatty acid fed to the 
sow could have impacted the fetuses’ rate of  
 
transcription of mRNA stability of the IGF 
mRNA by increasing its half-life. 
 
There were day effects detected in the en-
dometrium and conceptus for all the IGF 
genes studied.  In particular the interval from 
d 11 to d 15 seems to be a period when the 
IGF system is upregulated in these tissues.  In 
the conceptus IGF-II and IGFBP-3 continued 
to increase to d 19, while IGFBP-3 showed a 
similar but less dramatic increase from d 15 to 
d 19 in the endometrium.  These changes oc-
cur during a period of blastocyst elongation 
and attachment, embryogenesis and growth of 
tissues.  
 
It is important to determine whether ma-
ternal fatty acid supplementation can modulate 
IGF signaling during this critical period of 
pregnancy.  More data on protein expression 
and potentially including samples for the indi-
vidual days from d 11 to 19 would expand our 
ability to evaluate this possibility.  It will ul-
timately be important to evaluate downstream 
physiologies such as steroid synthesis.  
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